COVID drug trial for kids halted early
NCT ID NCT05074420
First seen Sep 30, 2025 · Last updated Jun 17, 2026 · Updated 39 times
Summary
This study tested the drug baricitinib in children aged 1 to 18 who were hospitalized with COVID-19 and needed extra oxygen. The goal was to see if the drug was safe and how it worked in kids. Only 6 children took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
-
CECIP - Centro de Estudos do Interior Paulista
Jaú, 17201130, Brazil
-
Centro de Pesquisa Sao Lucas
Campinas, 13034-685, Brazil
-
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
-
Complejo Hospitalario de Navarra
Pamplona, 31009, Spain
-
Hospital Infantil de Mexico Federico Gomez
Mexico City, 06720, Mexico
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario de Araba (HUA)- Hospital Txagorritxu
Vitoria-Gasteiz, 01009, Spain
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, 90410000, Brazil
-
Instituto Nacional de Pediatria
Mexico City, 04530, Mexico
-
Instituto de Pesquisa clinica de Campinas
Campinas, 13060-080, Brazil
-
Pesquisare Saude
Santo André, 09080-110, Brazil
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.